Fingerprint
Dive into the research topics where takuya adachi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Borderline Resectable Classification Identifies Candidates for Conversion Therapy in Unresectable Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab
Takeuchi, Y., Sue, M., Miyake, N., Adachi, T., Onishi, H., Kawanaka, M., Takaki, A., Nouso, K., Kariyama, K., Nakamura, S., Tanaka, E., Tada, T., Yasunaka, T., Kuwaki, K., Toshimori, J., Iwado, S., Moriya, A., Hagihara, H., Takabatake, H. & Sakata, M. & 1 others, , 2026, (Accepted/In press) In: Hepatology Research.Research output: Contribution to journal › Article › peer-review
Open Access -
Nationwide comprehensive genomic profiling defines the genomic landscape of hepatocellular carcinoma across etiologies
Yasugi, K., Kono, Y., Tsutsumi, K., Horiguchi, S., Sakaguchi, C., Ozato, T., Adachi, T., Takeuchi, Y., Onishi, H., Kawanaka, M., Takaki, A. & Otsuka, M., Dec 2026, In: Scientific reports. 16, 1, 1101.Research output: Contribution to journal › Article › peer-review
Open Access -
Clinical Variables That Predict Liver-related Events in Steatotic Liver Disease Diagnosed by a Liver Biopsy
Okubo, S., Takaki, A., Sato, I., Adachi, T., Takeuchi, Y., Sue, M., Miyake, N., Onishi, H., Hirohata, S. & Otsuka, M., Aug 15 2025, In: Internal Medicine. 64, 16, p. 2425-2432 8 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Local Control of Conjunctival Malignant Melanoma by Proton Beam Therapy in a Patient With No Metastasis in Six Years From in Situ to Nodular Lesions
Matsuo, T., Ogata, T., Waki, T., Tanaka, T., Tachibana, K., Fuji, T., Adachi, T. & Yamasaki, O., 2025, In: Journal of Medical Cases. 16, 1, p. 28-36 9 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Citation (Scopus) -
Predictive factors for transition to conversion therapy in hepatocellular carcinoma using atezolizumab plus bevacizumab
Kikuchi, T., Takeuchi, Y., Nouso, K., Kariyama, K., Kuwaki, K., Toshimori, J., Iwado, S., Moriya, A., Hagihara, H., Takabatake, H., Tada, T., Yasunaka, T., Sakata, M., Sue, M., Miyake, N., Adachi, T., Wada, N., Onishi, H., Shiraha, H. & Takaki, A. & 1 others, , Jun 2024, In: Liver International. 44, 6, p. 1456-1463 8 p.Research output: Contribution to journal › Article › peer-review
Open Access16 Link opens in a new tab Citations (Scopus)